No Detail Found!

Eugenol and liposome-based nanocarriers loaded with eugenol protect against anxiolytic disorder via down regulation of neurokinin-1 receptors in mice

Author(s)
Fahad Jibran Siyal Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan; Institute of Pharmacy, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana, Pakistan
Zahida Memon Department of Pharmacology, Ziauddin Medical College, Ziauddin University,Karachi,Pakistan
Rehan Ahmed Siddiqui Department of Research, Ziauddin University,Karachi,Pakistan
Zara Aslam HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,Karachi, Pakistan
Uzair Nisar Department of Pharmacology, Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Rehan Imad Department of Research, Ziauddin University,Karachi, Pakistan
Muhammad Raza Shah HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,Karachi, Pakistan
Abstract
Anxiety disorder is a psychiatric disorder characterized by extreme fear or worry. It is highly prevalent worldwide which affects daily life and is also an enormous health burden. Neurokinin 1 receptor (NK1R) is a G protein coupled receptor, expressed in both central and peripheral nervous system, involved in affective behaviors. NK1R has established role in anxiety and it is also an important target for pathogenesis of anxiety disorder. Therefore, it has been hypothesized in previous studies that the blockades of NK1R may have antidepressant and anxiolytic effects. The present study deals with the molecular mechanism of protective activity of eugenol against anxiolytic disorder. A pre-clinical animal study was performed on 42 BALB/c mice. Animals were given stress through conventional restrain model. The mRNA expression of NK1R was analyzed by real time RT-PCR. Moreover, the NK1R protein expression was also examined by immunohistochemistry in whole brain and mean density was calculated. The mRNA and protein expressions were found to be increased in animals given anxiety as compared to the normal control. Whereas, the expressions were decreased in the animals treated with eugenol and its liposome-based nanocarriers in a dose dependent manner. However, the results were better in animals treated with nanocarriers as compared to the compound alone. It is concluded that the eugenol and its liposome-based nanocarriers exert anxiolytic activity by down-regulating NK1R protein expression in mice.
Publication Details
Page(s) 2275-2284
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP5, Year: 2020

Request the full text from PASTIC

Keywords
liposome, Eugenol, anxiolytic activity, Anxiety, NK1R protein, nanocarriers
References
Botta P,Demmou L,Kasugai Y,Markovic M,Xu C,Fadok J P and Rudolph U .2015 .Regulating anxiety with extrasynaptic inhibition. Nat. Neurosci., 18(10) : 1493-1500.
Boyce S,Smith D,Carlson E,Hewson L,Rigby M,O'Donnell R,Harrison T,Rupniak N M .2001 .Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guineapigs. , 41 : 130-137.
Commons KG,Valentino RJ .2002 .Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J. Comp. Neurol., 447 : 82-97.
Cui F,Shi K,Zhang L,Tao A,Kawashima Y .2006 .Biodegradable nanoparticles loaded with insulinphospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J. Contr. Rel., 114(2) : 242-250.
Ebner K and Singewald N .2006 .The role of substance P in stress and anxiety responses. Amino Acids, 31(3) : 251-272.
Ebner K,Muigg P,Singewald G,Singewald N G .2008 .Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. , 1144(1) : 61-73.
Ebner K and Singewald N .2005 .Effects of NK1 receptor antagonist administration on basal and stressinduced substance P release in the amygdala. J. Neurochem., 94(Suppl) : 183.
Frick A,Åhs F,Palmquist Å M,Pissiota A,Wallenquist U,Fernandez M,Furmark T .2016 .Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multitracer PET study. Mol. Psych, 21(10) : 1400-1407.
Froger N,Gardier AM,Moratalla R,Alberti I,Lena I,Boni C,De Felipe C,Rupniak NM,Hunt SP,Jacquot C,Hamon M,Lanfumey L M .2001 .5- hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knockout mice mimic antidepressantinduced desensitization. J. Neurosci., 21 : 8188-8197.
Fuchs RA,Weber SM,Rice HJ,Neisewander JL HJ .2002 .Effects of excitotoxic lesions of the basolateral amygdala on cocaine-seeking behavior and cocaine conditioned place preference in rats. Brain Res., 929 : 15-25.
Gadd CA,Murtra P,De Felipe C and Hunt SP P .2003 .Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J. Neurosci., 23(23) : 8271-8280.
Garcia-Recio S,Gascon P .2015 .Biological and pharmacological aspects of the NK1-receptor. Bio Med. Res. Int.,, : .
Gupta U,Singh V K,Kumar V,Khajuria Y .2014 .Spectroscopic studies of cholesterol: Fourier transform infra-red and vibrational frequency analysis. Mater. Focus, 3(3) : 211-217.
Halder S,Mehta AK,Kar R,Mustafa M,Mediratta PK,Sharma KK .2011 .Clove oil reverses learning and memory deficits in scopolamine-treated mice. Planta Med, 77(08) : 830-834.
Hidayah N .2018 .The effect of papain enzyme dosage on the modification of egg-yolk lecithin emulsifier product through enzymatic hydrolysis reaction. Int. J. Tech., 9(2) : 380-389.
.1986 .Guide for the care and use of laboratory animals (No. 86). US Department of Health and Human Services, : .
Maubach KA,Martin K,Smith DW,Hewson L,Frankshun RA,Harrison T,Seabrook GR .2001 .Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro. , 40 : 806-817.
Mohammadi M,Ghanbarzadeh B,Hamishehkar H B .2014 .Formulation of nanoliposomal vitamin D3 for potential application in beverage fortification. Adv. Pharm. Bull., 4(Suppl) : 569.
Nguyen TL,Nguyen TH,Nguyen DH .2017 .Development and in vitro evaluation of liposomes using soy lecithin to encapsulate paclitaxel. 2017: Article ID 8234712., : .
Nikalje AP .2015 .Nanotechnology and its applications in medicine. Med, 5(2) : 081-089.
Parkinson JA,Crofts HS,McGuigan M,Tomic DL,Everitt BJ,Roberts AC .2001 .The role of the primate amygdala in conditioned reinforcement. J. Neurosci., 21 : 7770-7780.
Davis Parsafar P,EL Parsafar P .2018 .The function of emotions: When and why emotions help us. Cham: Spr. Int. Pub., : 9-23.
Perusini JN,Fanselow MS .2015 .Neurobehavioral perspectives on the distinction between fear and anxiety. , 22(9) : 417-425.
Ribeiro-da-Silva A,HE o okfelt T .2000 .Neuroanatomical localisation of substance P in the CNS and sensory neurons. , 34 : 256-271.
Santarelli L,Gobbi G,Debs PC,Sibille EL,Blier P,Hen R,Heath MJ R .2001 .Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. USA, 98 : 1912-1917.
Selvan P,Malathi RR,Rajan RR .2016 .Effect of 4- Allyl-2-methoxyphenol (eugenol) on motor coordination in subacute restraint stress Induced wistar albino rats. J. App. Pharm., 6(11) : 120-125.
Sharma M,Rauniar GP,Das BP .2012 .Experimental study of various central nervous system effects of eugenol in mice and rats. , 10(3) : 208-214.
Shults CW,Quirion R,Chronwall B,Chase TN,O'Donohue TL TN .1984 .A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides, 5 : 1097-112.
Siddiqui RA,Simjee SU,Kabir N,Ateeq M,Shah MR,Hussain SS .2019 .N-(2-hydroxyphenyl) acetamide and its gold nanoparticle conjugation prevent glycerol-induced acute kidney injury by attenuating inflammation and oxidative injury in mice. Mol. Cell Biochem, 450(1-2) : 43-52.
Silvianti F,Siswanta D,Aprilita NH,Kiswandono AA .2017 .Adsorption characteristic of iron onto Poly [eugenol-co-(divinyl benzene)] from Aqueous solution. J. Nat., 17(2) : 108-117.
Ständer S and Yosipovitch G .2019 .Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus. Br. J. Dermatol., 181(5) : 932-938.
Tovoten P,Fadok J P and Luthi A .2015 .Neuronal circuits for fear and anxiety. Nat. Rev. Neurosci., 16(6) : 317-331.
Varty GB,Cohen-Williams ME,Morgan CA,Pylak U,Duffy RA,Lachowicz JE,Carey GJ,Coffin VL .2002 .The gerbil elevated plus-maze II: Anxiolyticlike effects of selective neurokinin NK1 receptor antagonists. , 27 : 371-379.
0

Citations

0

Downloads

10

Views